Balsalazide

Discover Balsalazide, a medication primarily used to treat ulcerative colitis. Learn about its mechanism, medical uses, dosage, potential side effects, and

Balsalazide Balsalazide disodium Balsalazide ulcerative colitis treatment Balsalazide mechanism of action Balsalazide side effects Balsalazide dosage Colazal uses Ulcerative colitis medication 5-aminosalicylic acid
🏷 ATC Code: A07EC02 📂 Anti-inflammatory agents for intestinal diseases, Aminosalicylic acid and similar agents 🕐 Updated: Mar 12, 2026 ✓ Medical Reference

Looking to order Balsalazide?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Balsalazide?

Balsalazide is an aminosalicylate medication primarily used to treat inflammatory bowel diseases. Specifically, it is prescribed for the management of mild to moderate active ulcerative colitis, a chronic condition characterized by inflammation and ulcers in the lining of the large intestine (colon and rectum). Balsalazide is a prodrug, meaning it is an inactive compound that is converted into an active drug within the body. Its active component is mesalamine, also known as 5-aminosalicylic acid (5-ASA), which is a well-established anti-inflammatory agent in gastroenterology. Often found under brand names like Colazal or Giazo, Balsalazide is designed to deliver its therapeutic effects directly to the inflamed areas of the colon, minimizing systemic exposure and potential side effects.

How Does it Work?

The mechanism of action for Balsalazide is centered on its targeted delivery of mesalamine. Unlike other forms of mesalamine that might be absorbed higher in the digestive tract, Balsalazide is chemically structured with an azo bond that connects mesalamine to an inert carrier molecule. This azo bond remains intact in the acidic environment of the stomach and small intestine, preventing premature release of the active drug. Once Balsalazide reaches the colon, the azo bond is cleaved by specific enzymes produced by colonic bacteria. This bacterial action releases mesalamine (5-ASA) directly at the site of inflammation.

Once released, mesalamine exerts its therapeutic effects locally within the bowel wall. Its primary actions include inhibiting the production of prostaglandins and leukotrienes, which are inflammatory mediators. Mesalamine also scavenges free radicals and reactive oxygen species, further reducing cellular damage and inflammation. By targeting the drug delivery to the colon, Balsalazide helps to reduce gastrointestinal inflammation effectively while limiting the systemic absorption of mesalamine, which contributes to a more favorable side effect profile compared to orally administered steroids or systemically absorbed 5-ASA formulations.

Medical Uses

The primary medical use of Balsalazide is for the treatment of active ulcerative colitis. It is particularly effective for inducing remission in patients experiencing mild to moderate flares of the disease. By reducing inflammation in the colon, Balsalazide helps alleviate symptoms such as diarrhea, rectal bleeding, abdominal pain, and urgency. While primarily used for active disease, some healthcare providers may consider it for maintaining remission, although other 5-ASA formulations are often preferred for long-term maintenance therapy due to different release profiles and dosing schedules. It is not indicated for Crohn's disease or other forms of inflammatory bowel disease.

Dosage

The typical adult dosage for Balsalazide in the treatment of active mild to moderate ulcerative colitis is 6.75 grams (three 2.25g capsules or tablets) taken orally three times daily, for a duration of 8 to 12 weeks. It is crucial to follow the specific instructions provided by your healthcare professional, as dosages can vary based on the severity of the condition, patient response, and other individual factors. Balsalazide capsules should be swallowed whole and not opened, crushed, or chewed, to ensure proper delivery of the medication to the colon. Consistent administration at regular intervals is important for achieving optimal therapeutic effects. If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose, in which case the missed dose should be skipped.

Side Effects

Like all medications, Balsalazide can cause side effects, although not everyone experiences them. Common side effects often include headache, nausea, abdominal pain, diarrhea, and vomiting. These are generally mild and may subside as the body adjusts to the medication. Less common but potentially more serious side effects can include hypersensitivity reactions (e.g., rash, fever, difficulty breathing), liver enzyme elevations, kidney problems (though rare with 5-ASA derivatives, regular monitoring may be advised), and pancreatitis. In some rare cases, patients may experience a worsening of colitis symptoms, known as a paradoxical effect. It is important to contact your doctor immediately if you experience severe abdominal pain, persistent nausea or vomiting, dark urine, yellowing of the skin or eyes, or any signs of an allergic reaction. Regular follow-up with your healthcare provider is essential to monitor for any adverse effects.

Drug Interactions

While Balsalazide primarily acts locally, it's important to be aware of potential drug interactions. Concomitant use with azathioprine or mercaptopurine may increase the risk of myelosuppression (a decrease in bone marrow activity), necessitating careful monitoring of blood counts. Nonsteroidal anti-inflammatory drugs (NSAIDs) may theoretically increase the risk of nephrotoxicity when used with 5-ASA compounds, although this interaction is considered rare with Balsalazide due to its targeted release. Additionally, there have been isolated reports of altered international normalized ratio (INR) when 5-ASA products are co-administered with warfarin, so patients on anticoagulant therapy should be closely monitored. Always inform your doctor and pharmacist about all medications, supplements, and herbal products you are currently taking to prevent potential interactions.

FAQ

Is Balsalazide a steroid?

No, Balsalazide is not a steroid. It belongs to a class of drugs called aminosalicylates, which are anti-inflammatory agents structurally related to aspirin but work differently to reduce inflammation in the gut.

How long does it take for Balsalazide to work?

While some patients may experience symptom improvement within a few weeks, the full therapeutic effect of Balsalazide typically takes 8 to 12 weeks to become apparent, especially for inducing remission in active ulcerative colitis.

Can I take Balsalazide long-term?

Balsalazide is primarily indicated for the treatment of active disease. For long-term maintenance of remission, other 5-ASA formulations or different medications might be preferred. Your doctor will determine the appropriate duration of treatment based on your condition and response.

What should I do if I miss a dose?

If you miss a dose of Balsalazide, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.

Can pregnant or breastfeeding women take Balsalazide?

The use of Balsalazide during pregnancy and breastfeeding should be discussed with a healthcare professional. While studies have not shown significant harm, the risks and benefits must be carefully weighed. It is crucial to follow your doctor's advice.

Products containing Balsalazide are available through trusted online pharmacies. You can browse Balsalazide-based medications at ShipperVIP or Medicenter.

Summary

Balsalazide is an important medication in the management of mild to moderate active ulcerative colitis. As a prodrug, it effectively delivers its active component, mesalamine, directly to the inflamed colon, providing localized anti-inflammatory action. This targeted approach helps alleviate symptoms and induce remission with potentially fewer systemic side effects. While generally well-tolerated, it is crucial for patients to adhere to prescribed dosages, be aware of potential side effects, and discuss any concerns or drug interactions with their healthcare provider. Regular medical follow-up ensures optimal treatment outcomes and safe use of Balsalazide in managing this chronic inflammatory bowel disease.